LENZ THERAPEUTICS, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$19M
Cost of Revenue
$418K
R&D
$19M
SG&A
$91M
D&A
$287K
Operating Income
$-91M
EBITDA
$-91M
Interest Income
$10M
Other Income/Expense
$-243K
Pretax Income
$-82M
Tax Provision
$502K
Net Income
$-82M
Operating Margin
-477.5%
Net Margin
-430.3%
Effective Tax Rate
-0.6%
Deferred Tax Assets
$488K
Deferred Tax Liabilities
—
DTA Valuation Allowance
$70M
Tax Credit Carryforwards
$9M
NOL Carryforwards
$38M
ETR (Continuing Operations)
-0.6%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-0.3%
Operating Lease Cost
$500K
Income YoY Variation
-55.5%